Y10S 424/00
Drug, bio-affecting and body treating compositions
Y10S424/00 (Drug, bio-affecting and body treating compositions) appears on 3,802 US grants and 877 published applications in this corpus.
Search patents in Y10S- Granted patents
- 3,802
- Published applications
- 877
- Assignees
- 1,344
- Inventors
- 5,482
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 123 | 0 |
| 1977 | 83 | 0 |
| 1978 | 63 | 0 |
| 1979 | 64 | 0 |
| 1980 | 82 | 0 |
| 1981 | 74 | 0 |
| 1982 | 75 | 0 |
| 1983 | 60 | 0 |
| 1984 | 77 | 0 |
| 1985 | 69 | 0 |
| 1986 | 62 | 0 |
| 1987 | 115 | 0 |
| 1988 | 108 | 0 |
| 1989 | 119 | 0 |
| 1990 | 99 | 0 |
| 1991 | 119 | 0 |
| 1992 | 120 | 0 |
| 1993 | 138 | 0 |
| 1994 | 125 | 0 |
| 1995 | 102 | 0 |
| 1996 | 118 | 0 |
| 1997 | 172 | 0 |
| 1998 | 205 | 0 |
| 1999 | 194 | 0 |
| 2000 | 169 | 0 |
| 2001 | 159 | 42 |
| 2002 | 158 | 118 |
| 2003 | 116 | 124 |
| 2004 | 95 | 77 |
| 2005 | 50 | 87 |
| 2006 | 65 | 53 |
| 2007 | 55 | 47 |
| 2008 | 52 | 57 |
| 2009 | 52 | 44 |
| 2010 | 39 | 45 |
| 2011 | 52 | 35 |
| 2012 | 36 | 37 |
| 2013 | 23 | 23 |
| 2014 | 40 | 23 |
| 2015 | 28 | 19 |
| 2016 | 12 | 12 |
| 2017 | 8 | 7 |
| 2018 | 7 | 11 |
| 2019 | 7 | 6 |
| 2020 | 6 | 2 |
| 2021 | 2 | 4 |
| 2022 | 0 | 0 |
| 2023 | 3 | 2 |
| 2024 | 1 | 0 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- Y10S 424/05Stick487
- Y10S 424/10Insect repellent390
- Y10S 424/02Resin hair settings373
- Y10S 424/01Aerosol hair preparation320
- Y10S 424/81Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy270
- Y10S 424/13Burn treatment191
- Y10S 424/08Systemic pesticides156
- Y10S 424/11Termite treating150
All 48 subgroupsShow fewer
- Y10S 424/15Suppositories145
- Y10S 424/809Involving immunoglobulin or antibody fragment137
- Y10S 424/812Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific136
- Y10S 424/04Dandruff135
- Y10S 424/16Dendrimers and dendritic polymers117
- Y10S 424/825Bacterial vaccine for porcine species103
- Y10S 424/06Chelate102
- Y10S 424/831Involving capsular polysaccharide of bacterium100
- Y10S 424/816Viral vaccine for avian species96
- Y10S 424/14Topical contraceptives and spermacides95
- Y10S 424/823Bacterial vaccine for bovine species85
- Y10S 424/811Involving sex selection or contraception76
- Y10S 424/832Involving bacterial toxin that has modified amino acid sequence71
- Y10S 424/805Involving ige or igd65
- Y10S 424/80Antibody or fragment thereof whose amino acid sequence is disclosed in whole60
- Y10S 424/806Involving igm60
- Y10S 424/826Bacterial vaccine for avian species59
- Y10S 424/801Involving antibody or fragment thereof produced by recombinant dna technology56
- Y10S 424/804Involving igg3, igg4, iga, or igy53
- Y10S 424/815Viral vaccine for porcine species52
- Y10S 424/03Hair bleach49
- Y10S 424/12Fertilization attaching inhibition49
- Y10S 424/828Bacterial vaccine for canidae or mustelidae44
- Y10S 424/824Bacterial vaccine for ovine species43
- Y10S 424/07Microporous membranes41
- Y10S 424/829Bacterial vaccine for equine species39
- Y10S 424/819Viral vaccine for feline species37
- Y10S 424/818Viral vaccine for canidae or mustelidae31
- Y10S 424/827Bacterial vaccine for fish30
- Y10S 424/90In vivo diagnostic or in vivo test agent which contains an additional30
- Y10S 424/813Viral vaccine for bovine species26
- Y10S 424/09Fish posts18
- Y10S 424/802Antibody or antigen-binding fragment thereof that binds gram-positive bacteria15
- Y10S 424/803Antibody or antigen-binding fragment thereof that binds gram-negative bacteria15
- Y10S 424/821Involving temperature-sensitive mutant virus13
- Y10S 424/822Involving tk- virus12
- Y10S 424/817Viral vaccine for fish11
- Y10S 424/82Viral vaccine for equine species9
- Y10S 424/83Involving temperature-sensitive mutant bacterium6
- Y10S 424/814Viral vaccine for ovine species5
Recent patents
- Anti-PCSK9 antibodies8 Apr 2025US 12,269,897 B2Regeneron Pharmaceuticals, Inc.
- Drug delivery systems and methods for making and using the same1 Oct 2024US 12,102,711 B1NexGen Semi Holding, Inc.
- Drug delivery systems and methods for making and using the same29 Aug 2023US 11,737,970 B1NexGen Semi Holding, Inc.
- Immunogenic compositions comprising Lawsonia intracellularis29 Aug 2023US 11,738,077 B2
- Bifidobacterium bifidum strain and strain-derived polysaccharide30 May 2023US 11,660,312 B2Institute for Basic Science
- Systems and methods for improved in vivo analyte sensor function22 May 2025US 2025/0160698 A1Abbott Diabetes Care Inc.
- Anti-pcsk9 antibodies15 May 2025US 2025/0154286 A1Regeneron Pharmaceuticals, Inc.
- Anti-pcsk9 antibodies26 Oct 2023US 2023/0340153 A1Regeneron Pharmaceuticals, Inc.
- Immunogenic compositions comprising lawsonia intracellularis28 Sep 2023US 2023/0302111 A1Boehringer Ingelheim Animal Health USA Inc.
- Antibodies against clostridium difficile toxins and uses thereof2 Sep 2021US 2021/0269511 A1E. R. Squibb & Sons, Inc.
Most cited
By later US patents
- Recombinant altered antibodies and methods of making altered antibodies1,968US 5,225,539 AMedical Research Council · 1993
- Method of encapsulating biologically active materials in lipid vesicles1,201US 4,235,871 A1980
- Prosthetic disc and method of implanting1,066US 4,772,287 ACedar Surgical, Inc. · 1988
- Liposomes containing modified cholesterol for organ targeting853US 4,544,545 ATrustees of the University of Massachusetts · 1985
- Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma744US 5,736,137 AIDEC Pharmaceuticals Corporation · 1998